Salarius Pharmaceuticals renames to Decoy Therapeutics; ticker changes to DCOY effective Jan 8, 2026

Decoy Therapeutics Inc.

Name change to Decoy Therapeutics Inc. and ticker symbol change from SLRX to DCOY effective January 8, 2026.
No change to shares outstanding, shareholder rights, CUSIP number, or transfer agent.
Focus on AI-enabled peptide-conjugate platform; lead antiviral program attracts BARDA interest.
2026 priorities: advance lead into clinic, expand pipeline, pursue partnerships, and strengthen capital structure.
Company to launch new website decoytx.com for investor relations.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Decoy Therapeutics Inc.: Changed the legal name of the company from Salarius Pharmaceuticals, Inc. to Decoy Therapeutics Inc (effective 2026-01-08).

Change: charter amendment
Effective: 2026-01-08

Exact text from the filing

On January 7, 2026, Salarius Pharmaceuticals, Inc. (the “ Company ” or the “Registrant” ) announced that it has filed a Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended (“Certificate of Amendment”) with the Secretary of State of the State of Delaware to change the legal name of the Company from “Salarius Pharmaceuticals, Inc.” to “Decoy Therapeutics Inc.,” effective as of January 8 , 2026 (the “Name Change”).

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Decoy Therapeutics Inc.: Approved an amendment and restatement of the Amended and Restated Bylaws to reflect the name change (effective 2026-01-08).

Change: bylaw amendment
Effective: 2026-01-08

Exact text from the filing

In connection with the Name Change, the Board of Directors of the Company approved an amendment and restatement of the Company’s Amended and Restated Bylaws, as amended (the “Second Amended and Restated Bylaws”), effective as of January 8 , 2026. The Amended and Restated Bylaws reflect the Name Change.

View on SEC.gov

51 governance changes filed in the last 30 days. Browse all governance changes →

Decoy Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001615219-26-000013

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.